Matthew Scholz
Gründer bei Immusoft Corp.
Profil
Founder of Immusoft Corp., Oisin Biotechnologies, Inc. and OncoSenx, Inc., Matthew Scholz presently holds the position of President, Chief Executive Officer & Director at Oisin Biotechnologies, Inc. and Chief Executive Officer of OncoSenx, Inc. He is also on the board of Immusoft Corp.
(former Director & Chief Technology Officer).
Aktive Positionen von Matthew Scholz
| Unternehmen | Position | Beginn |
|---|---|---|
Immusoft Corp.
 Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Gründer | 01.01.2009 |
Oisin Biotechnologies, Inc.
 Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Gründer | 25.02.2014 |
OncoSenx, Inc.
 OncoSenx, Inc. Pharmaceuticals: MajorHealth Technology Oncosenx, Inc. engages in the development of transient gene therapies which are designed for solid tumors. The company was founded in 2017 by Matthew Scholz, John D. Lewis, Gary C.Hudson and Eric Garcia and is headquartered in Seattle, WA. | Vorstandsvorsitzender | 01.07.2018 |
Aegis Life, Inc.
 Aegis Life, Inc. BiotechnologyHealth Technology Aegis Life, Inc. is an American San Diego-based company founded in 2020 by Hong Jiang, Matthew Scholz, John Lewis, and Roy Duncan. The company develops the next generation of DNA vaccines and therapies for the world's most dangerous diseases, using the Fusogenix gene delivery platform developed by parent company Entos Pharmaceuticals. This breakthrough non-viral gene delivery platform allows Aegis Life to rapidly prototype and advance DNA medicines through the clinical trial process. John Lewis has been the CEO since 2020. | Gründer | 01.03.2020 |
Sigma Genetics, Inc.
 Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Sigma Genetics, Inc. manufactures non-invasive devices. The American company was founded by Matthew Scholz, Karen Eaton. | Gründer | 01.10.2016 |
Methuselah Capital Management LLC
 Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Berater | - |
Ehemalige bekannte Positionen von Matthew Scholz
| Unternehmen | Position | Ende |
|---|---|---|
Point B Telematics, Inc.
 Point B Telematics, Inc. Packaged SoftwareTechnology Services Point B Telematics, Inc. is a technology leader in its field. The firm provides logistics technology solutions for fleet managers, dispatchers, and operations managers in the United States. It offers WIMFleet and fleet tracking tool. It installs a GPS tracking device in vehicles. The application shows you where your vehicles are and provides advanced reports and tools to optimize the use of your fleet. | Vorstandsvorsitzender | 01.10.2008 |
Ausbildung von Matthew Scholz
| University of Washington | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Immusoft Corp.
Immusoft Corp. Medical/Nursing ServicesHealth Services Immusoft Corp. provides disease curing services through immune cells. The firm offers ISP, gene delivery technology and lymphopoiesis culture system. The company was founded by Matthew Scholz in 2009 and is headquartered in Seattle, WA. | Health Services |
Point B Telematics, Inc.
Point B Telematics, Inc. Packaged SoftwareTechnology Services Point B Telematics, Inc. is a technology leader in its field. The firm provides logistics technology solutions for fleet managers, dispatchers, and operations managers in the United States. It offers WIMFleet and fleet tracking tool. It installs a GPS tracking device in vehicles. The application shows you where your vehicles are and provides advanced reports and tools to optimize the use of your fleet. | Technology Services |
Oisin Biotechnologies, Inc.
Oisin Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Oisin Biotechnologies, Inc. operates as a drug development company. It engages in the provision of biological solutions to degenerative aging conditions. The company was founded by Gary Hudson, Kevin Perrott, Matthew Scholz and John Lewis in 2014 and is headquartered in Seattle, WA. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
OncoSenx, Inc.
OncoSenx, Inc. Pharmaceuticals: MajorHealth Technology Oncosenx, Inc. engages in the development of transient gene therapies which are designed for solid tumors. The company was founded in 2017 by Matthew Scholz, John D. Lewis, Gary C.Hudson and Eric Garcia and is headquartered in Seattle, WA. | Health Technology |
Sigma Genetics, Inc.
Sigma Genetics, Inc. Medical SpecialtiesHealth Technology Sigma Genetics, Inc. manufactures non-invasive devices. The American company was founded by Matthew Scholz, Karen Eaton. | Health Technology |
Aegis Life, Inc.
Aegis Life, Inc. BiotechnologyHealth Technology Aegis Life, Inc. is an American San Diego-based company founded in 2020 by Hong Jiang, Matthew Scholz, John Lewis, and Roy Duncan. The company develops the next generation of DNA vaccines and therapies for the world's most dangerous diseases, using the Fusogenix gene delivery platform developed by parent company Entos Pharmaceuticals. This breakthrough non-viral gene delivery platform allows Aegis Life to rapidly prototype and advance DNA medicines through the clinical trial process. John Lewis has been the CEO since 2020. | Health Technology |
